Matches in Wikidata for { <http://www.wikidata.org/entity/Q64680682> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q64680682 description "clinical trial" @default.
- Q64680682 description "ensayu clínicu" @default.
- Q64680682 description "klinisch onderzoek" @default.
- Q64680682 description "клінічне випробування" @default.
- Q64680682 name "Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery" @default.
- Q64680682 type Item @default.
- Q64680682 label "Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery" @default.
- Q64680682 prefLabel "Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery" @default.
- Q64680682 P1132 Q64680682-B008596D-45E2-4E97-89D8-40844AB66568 @default.
- Q64680682 P1476 Q64680682-814F77E6-F8CC-449B-9368-53A3D4069144 @default.
- Q64680682 P17 Q64680682-354EC636-38F4-4497-ADDC-A7D4D90BA148 @default.
- Q64680682 P17 Q64680682-65C06008-FA00-430E-B6FA-8119C6C60389 @default.
- Q64680682 P17 Q64680682-8EF474A2-3B34-482C-B684-3E9952CD30D2 @default.
- Q64680682 P17 Q64680682-A93378C5-793A-4E1B-9BE1-A18BEBD97635 @default.
- Q64680682 P17 Q64680682-E4947BBE-11B5-4421-8E9D-EF87019E592B @default.
- Q64680682 P17 Q64680682-EDA5AB66-52DB-428D-9C39-FB53EE3C6FB9 @default.
- Q64680682 P17 Q64680682-EDADFF7B-8E45-4D1A-B65F-9EF276A22075 @default.
- Q64680682 P2899 Q64680682-72FC4D2C-279B-4DB2-A355-102661BD0B4C @default.
- Q64680682 P3098 Q64680682-8A880A79-CFD4-4F98-B944-1DA76F0BBB56 @default.
- Q64680682 P31 Q64680682-9A374C0A-2E54-48A3-8C13-FA349AC54703 @default.
- Q64680682 P580 Q64680682-19D92515-CC39-4332-9EBC-F0E8D0FA85B9 @default.
- Q64680682 P582 Q64680682-588C417B-C413-4FC0-86EB-5439A14980F7 @default.
- Q64680682 P8363 Q64680682-9C729462-A4C5-4C74-B5E1-44F51B3793C8 @default.
- Q64680682 P1132 "+472" @default.
- Q64680682 P1476 "Observational Cohort Study to Evaluate Safety and Efficacy of Pradaxa (Dabigatran Etexilate) in Patients With Moderate Renal Impairment (Creatinine Clearance 30-50 ml/Min) Undergoing Elective Total Hip Replacement Surgery or Total Knee Replacement Surgery" @default.
- Q64680682 P17 Q142 @default.
- Q64680682 P17 Q145 @default.
- Q64680682 P17 Q183 @default.
- Q64680682 P17 Q29 @default.
- Q64680682 P17 Q34 @default.
- Q64680682 P17 Q38 @default.
- Q64680682 P17 Q40 @default.
- Q64680682 P2899 "+18" @default.
- Q64680682 P3098 "NCT00847301" @default.
- Q64680682 P31 Q30612 @default.
- Q64680682 P580 "2009-04-01T00:00:00Z" @default.
- Q64680682 P582 "2014-07-01T00:00:00Z" @default.
- Q64680682 P8363 Q818574 @default.